Skip to Content
Merck

Superoxide dismutase as a target of clioquinol-induced neurotoxicity.

Biochemical and biophysical research communications (2014-04-24)
Kazuyuki Kawamura, Yukiko Kuroda, Masako Sogo, Miki Fujimoto, Toshio Inui, Takao Mitsui
ABSTRACT

Subacute myelo-optico-neuropathy (SMON) is a progressive neurological disorder affecting the spinal cord, peripheral nerves and optic nerves. Although it has been assumed that SMON was caused by intoxication of clioquinol, the mechanism underlying clioquinol-induced neurotoxicity is not fully understood. This study aimed to clarify the relevance of oxidative stress to clioquinol-induced neurotoxicity and the cause of the enhanced oxidative stress. Clioquinol induced cell death in human-derived neuroblastoma cell line, SH-SY5Y, in a dose-dependent manner. This process was accompanied by activation of caspase-3 and enhanced production of reactive oxygen species (ROS). We examined whether clioquinol inhibited the activity of superoxide dismutase-1 (SOD1), based on its metal chelating properties. Clioquinol inhibited activities of purified SOD1 in a dose-dependent manner. Cytosolic SOD activities were also inhibited in SH-SY5Y cells treated with clioquinol. Finally, addition of exogenous SOD1 to the culture significantly reduced enhanced ROS production and cell death induced by clioquinol in SH-SY5Y cells. These findings suggested that enhanced oxidative stress caused by inhibition of SOD1 undelay clioquinol-induced neurotoxicity and was relevant to the pathogenesis of SMON.

MATERIALS
Product Number
Brand
Product Description

Supelco
Clioquinol, VETRANAL®, analytical standard
Clioquinol, European Pharmacopoeia (EP) Reference Standard
USP
Clioquinol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
5-Chloro-7-iodo-8-quinolinol, ≥95.0% (HPLC)